| Protocol No. | ClinicalTrials.gov Protocol No. | PI Name | Title | |||
| Pediatric Cancers > Leukemia and Lymphoma | ||||||
| AALL1721 | NCT03876769 | Hermiston, Michelle | Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (CASSIOPEIA) | |||
| AALL1821 | NCT04546399 | Huang, Benjamin | A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) | |||
| AALL1922 | NCT04501614 | Braun, Ben | A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | |||
| ADVL1521 | NCT03190915 | Stieglitz, Elliot | Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia | |||
| ADVL1822 | NCT03793478 | Vo, Kieuhoa | Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood | |||
| ADVL2111 | NCT05077423 | Stieglitz, Elliot | A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia | |||
| APAL2020SC | NCT04726241 | Stieglitz, Elliot | The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study | |||
| E4412 | NCT01896999 | Hermiston, Michelle | Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | |||
| Protocol No. | ClinicalTrials.gov Protocol No. | PI Name | Title | |||
| Pediatric Cancers > Histiocytic Disorders | ||||||
| NACHO LCH-IV | NCT02205762 | Hermiston, Michelle | LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis | |||
| NACHO HLHRUXO | NCT04551131 | Hermiston, Michelle | Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis | |||